J9029 – Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9029
- Long description
- Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
- Short description
- Instill adstiladrin, tx dose
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2023
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J9029?
J9029 is a HCPCS Level II code for intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose.
Does Medicare cover J9029?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9021 – Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 – Injection, atezolizumab, 10 mg
- J9023 – Injection, avelumab, 10 mg
- J9024 – Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 – Injection, azacitidine, 1 mg
- J9026 – Injection, tarlatamab-dlle, 1 mg
- J9027 – Injection, clofarabine, 1 mg
- J9028 – Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- J9030 – Bcg live intravesical instillation, 1 mg
- J9031 – Bcg (intravesical) per instillation
- J9032 – Injection, belinostat, 10 mg
- J9033 – Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
- J9034 – Injection, bendamustine hcl (bendeka), 1 mg
- J9035 – Injection, bevacizumab, 10 mg
- J9036 – Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
- J9037 – Injection, belantamab mafodotin-blmf, 0.5 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.